Type 2 Diabetes
FDA approves new Avandamet dosage strengths
Published in Obesity and Diabetes Week, September 22nd, 2003
The new Avandamet dosages of 1 gram metformin combined with 2 or 4 mg rosiglitazone will be available to patients this fall.
"GlaxoSmithKline is pleased with the FDA's approval of the new Avandamet 1 gram tablets as they will offer additional dosing flexibility for the many type 2 diabetes patients who are currently taking a total daily dose of 2 grams of metformin," said David Brand, vice president, metabolic/endocrine marketing, GlaxoSmithKline.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Animal Models
Mouse, stripped of a key gene, resists diabetes - Obesity Pathogenesis
Eating behavior associated with Rorschach characteristics in obesity - Childhood Obesity
American Academy of Pediatrics issues statement on childhood obesity - Diabetic Nephropathy
Ramipril prevents microtubular changes in proximal tubules from diabetic rats - Hypertension Risk Factor
Diabetic children have hypertension risks similar to obese children - Weight Reduction
Hydrodynamics augments leptin gene expression and increases weight loss in mice - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
